• MSR158 Successful Use of Propensity Score Methods for HTA in Germany: A Near-Impossible Task?

    Dec 1, 2023, 00:00

  • EE239 How to Consider Caregiver Health-Related Quality of Life in a Cost-Effectiveness Analysis? An Illustration with Dupilumab for the Treatment of Severe Atopic Dermatitis in Infants in France

    Dec 1, 2023, 00:00

  • EE251 The Impact of Cesarean Birth Complications on Maternal and Infant Health in the World and Turkiye

    Dec 1, 2023, 00:00

  • EE213 Presenting Expected Net Loss Curves to Better Communicate Decision Uncertainty in Cost Effectiveness Analysis

    Dec 1, 2023, 00:00

  • EPH204 Epidemiology and Patient Characteristics of Pemphigus Vulgaris in UK: A Retrospective Cohort Study Using Clinical Practice Research Datalink (CPRD) and Hospital Episode Statistics (HES)

    Dec 1, 2023, 00:00

  • HPR13 Unmet Needs in Rare Diseases: Insights on Definitions and Methodological Challenges From a Grey Literature Review

    Dec 1, 2023, 00:00

  • HTA202 Guideline for Costing in Italian Economic Evaluations: A Proposal of the ISPOR Italy Rome Chapter

    Dec 1, 2023, 00:00

  • EE158 Cost Effectiveness and Budget Impact of Patient Blood Management in a Turkish State Hospital

    Dec 1, 2023, 00:00

  • EE215 Estimation of 10-Year Healthcare Costs of Patients Diagnosed With Myeloproliferative Neoplasms in Denmark

    Dec 1, 2023, 00:00

  • MSR107 Estimating Optimal Personalized Treatment Sequencing for Patients with Multiple Myeloma Using Reinforcement Learning

    Dec 1, 2023, 00:00

  • HSD84 Financial Hardship from Neglected Tropical Diseases: A Systematic Literature Review and Meta-Analysis

    Dec 1, 2023, 00:00

  • HPR112 International Market Access Strategies for Artificial Intelligence-Based Medical Devices: Can We Standardized the Process to Faster Patient Access?

    Dec 1, 2023, 00:00

  • HTA48 Bridging the Gap: How to Align HTA and Health Care Decision Making in Switzerland

    Dec 1, 2023, 00:00

  • PCR213 Bridging the Practice to Theory Gap: Uncovering and Addressing Barriers and Facilitators to Evaluation of Patient Support Programs by the Pharmaceutical Industry

    Dec 1, 2023, 00:00

  • MSR14 Unleashing the Potential of Artificial Intelligence in Genomic Biomarker Testing for Precision Oncology: A Scoping Review

    Dec 1, 2023, 00:00

  • HSD50 Infantile Vaccination Coverage in Brazil From 2016-2022 – Effects of Pandemic Period in Non-COVID-19 Vaccination

    Dec 1, 2023, 00:00

  • EE312 Multi-Comparator ICERS in Cost-Effectiveness Analysis to Account for Changes in Clinical Practice after the Introduction of a New Technology

    Dec 1, 2023, 00:00

  • EPH99 Public Health Impact of Replacing Monovalent and Quadrivalent Meningococcal Vaccines By Pentavalent Vaccine in the United States

    Dec 1, 2023, 00:00

  • HPR187 Is the Older Adult Subgroup of the Rare Disease Population Marginalized on Purpose? an Analysis of Equity Issues Encountered By the (OLDER) Rare Disease Population

    Dec 1, 2023, 00:00

  • EE440 Cost-Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine in Indian Adults Aged ≥60 Years

    Dec 1, 2023, 00:00

  • HSD21 Regional Differences in the Use of Ige Testing in Primary Care: The Case of Sweden

    Dec 1, 2023, 00:00

  • EPH95 Claims Data Analysis of the Prevalence and Healthcare Resource Utilization of Chronic Kidney Disease-Associated Pruritus in German Hemodialysis Patients

    Dec 1, 2023, 00:00

  • HSD98 Patient Characteristics and Treatment Patterns in Patients with Advanced Psoriasis in Specialty Care Settings in Finland

    Dec 1, 2023, 00:00

  • MSR73 Methods for Incorporating External Eviden A Comparison of Their Impact on Extrapolations and Uncertainty Estimates Using a Melanoma Case-Study

    Dec 1, 2023, 00:00

  • EE701 Cost-Effectiveness Analysis of Polatuzumab Vedotin Combined with Chemoimmunotherapy in Untreated Diffuse Large B-Cell Lymphoma (DLBCL) in China

    Dec 1, 2023, 00:00

  • EPH158 Impact of Hepatitis B Virus (HBV) and Human Papilloma Virus (HPV) Related Cancers Elimination on Treatment Patterns in the United Kingdom (HELP-UK)

    Dec 1, 2023, 00:00

  • PCR210 Effectiveness of a Decision Aid for Parents/Caregivers of Children Needing Enteral Support

    Dec 1, 2023, 00:00

  • PCR254 Building a COA Strategy in Chronic Rhinosinusitis with or Without Nasal Polyps: Patient Experiences and Clinical Outcome Assessments from the Literature

    Dec 1, 2023, 00:00

  • SA48 Comparative Effectiveness Based on Win Ratios: Do Conventional ITC Approaches Work?

    Dec 1, 2023, 00:00

  • EE388 Cost of Illness for Advanced Hepatocellular Carcinoma (aHCC) in Ontario, Canada

    Dec 1, 2023, 00:00

  • SA33 The Role of Artificial Intelligence in Decoding the Placebo Response - Implications for Clinical Research and Practice

    Dec 1, 2023, 00:00

  • EE66 Cost Effectiveness Analysis of Pembrolizumab as First-Line Treatment for Persistent, Recurrent, or Metastatic Cervical Cancer in Greece

    Dec 1, 2023, 00:00

  • EE264 Cost-Effectiveness Analysis of Upadacitinib in Patients with Active Non-Radiographic Axial Spondyloarthritis in Greece

    Dec 1, 2023, 00:00

  • P42 Enhancing the Understanding of Phenotypic Outcomes in Sickle Cell Disease (SCD) Through a Comparison Between Data Collected Through App-Based Home-Reported Outcomes (HROs) Versus Qualitative Methodologies

    Dec 1, 2023, 00:00

  • EPH202 Current Policy, Clinical and Economic Environment of Eye Care and Vision Health in Bulgaria

    Dec 1, 2023, 00:00

  • PCR263 Design of a Patient-Informed Chronic Kidney Disease (CKD) Experience Interview Guide: Learnings From DISCOVER CKD

    Dec 1, 2023, 00:00

  • CO41 Long-Term Clinical Outcomes in People with Heart Failure with Preserved Ejection Fraction (HFpEF) Treated with Standard Care

    Dec 1, 2023, 00:00

  • RWD130 Healthcare Resource Utilization for Pediatric and Adolescent Duchenne Muscular Dystrophy Patients: Analysis of Real-World Data

    Dec 1, 2023, 00:00

  • MT13 Digging into the Medical Technology HTA Process in Tunisia

    Dec 1, 2023, 00:00

  • RWD5 Body Fatness Associations with Cancer: Retrospective Cohort Study from a Brazilian Health Management Organization (RWE)

    Dec 1, 2023, 00:00

  • HPR200 Evolution in Public Procurement for Medical Devices in Italy

    Dec 1, 2023, 00:00

  • HTA293 Challenges and Opportunities in Implementing the EUnetHTA21 Methodological Guidelines in the Context of EU HTA Regulation: Perspectives From Different Stakeholders on Different Markets (France, Italy, and Poland)

    Dec 1, 2023, 00:00

  • HTA199 Digital Health Application (DiGA) vs Other Digital Health Technologies (DHT) as Part of Disease Management Programs (DMP)—Assessment Requirements in Germany Diverge Between HTA Authorities

    Dec 1, 2023, 00:00

  • HPR165 Financial-Based Managed Entry Agreements for Drugs in Romania: From Simple to Complex

    Dec 1, 2023, 00:00

  • CO131 Using Non-Randomized Trials to Assess the Clinical Benefit of Systemic Anti-Cancer Treatments: Viable or Not?

    Dec 1, 2023, 00:00

  • HPR62 Impact of GKV Financial Stabilization Act on Drug Pricing in Germany – Early Experiences of the Reform

    Dec 1, 2023, 00:00

  • Table of Contents

    Dec 1, 2023, 00:00

  • HTA83 Economic Evaluations in Relapsed or Refractory (R/R) Follicular Lymphoma (FL): Challenges for Health Technology Assessment (HTA) Submissions

    Dec 1, 2023, 00:00

  • HTA52 Time to HTA Assessment Completion By HTA Agency Archetype: Five-Year Review for 20 European Countries

    Dec 1, 2023, 00:00

  • HTA11 Drivers of Positive Health Technology Assessment Outcomes for Oncology Drugs in Three Global Markets

    Dec 1, 2023, 00:00

  • EE692 Cost-Effectiveness of Nivolumab (NIVO) and NIVO in Combination With Ipilimumab (IPI) in First-Line Treatment of Advanced Melanoma in Colombia: Analysis Using 78-Month Overall Survival From CheckMate 067

    Dec 1, 2023, 00:00

  • HSD105 Pharmacists' Intervention in Access to Therapeutical Innovation in Portuguese Hospitals

    Dec 1, 2023, 00:00

  • P44 Seeing it in the Flesch: Comparing Readability Between AI-Generated and Human-Written Plain-Language Abstracts

    Dec 1, 2023, 00:00

  • EE89 Cost-Effectiveness Analysis of Onasemnogene Abeparvovec-Xioi (Zolgensma®) and Best Supportive Care Treatment for Spinal Muscular Atrophy I in the Netherlands With Early-Treatment Scenario

    Dec 1, 2023, 00:00

  • CO148 Effectiveness of Tocilizumab in Refractory Graves' Orbitopathy in a Real-World Setting

    Dec 1, 2023, 00:00

  • PT16 Impact of Data Maturity on the Estimation of the within-Trial Hazard Function: An Example from Metastatic Castration Resistant Prostate Cancer

    Dec 1, 2023, 00:00

  • CO71 Faricimab Versus Standard of Care in Naive Neovascular Age-Related Macular Degeneration Patients: An Indirect Treatment Comparison Using Individual Level Data

    Dec 1, 2023, 00:00

  • MT14 Inequity in Access to Breast Reconstruction Techniques in Belgian Health System: Is it Justified?

    Dec 1, 2023, 00:00

  • PCR106 Merging Adolescent and Adult Preference Data Into a Potential Latent Scale EQ-5D-Y-3L Value Set: A Latent Class Approach to Analyze Contribution of Each Group to the Preference Weights

    Dec 1, 2023, 00:00

  • HTA193 Benefits Not Captured in the Quality-Adjusted Life Year Calculation: What Role Do They Play in the National Institute for Health and Care Excellence's Updated Decision-Making Process?

    Dec 1, 2023, 00:00

  • PCR182 Patient Preferences for Tumor-Agnostic Therapies: Qualitative Insights and Challenges

    Dec 1, 2023, 00:00

  • HPR83 The Price Is Right or Is It? Navigating the Inflation Reduction Act (IRA) With Payer Perspectives on Evidence Needs, Fair Market Pricing, and Patient Access Implications

    Dec 1, 2023, 00:00

  • HSD122 A Systematic Review on Equal Access to Treatment for Hearing Loss in Chile: Do All People Have the Same Opportunities to Receive Appropriate Treatment?

    Dec 1, 2023, 00:00

  • RWD36 Immunoglobulin Use in France 2015 to 2022–Real-World Data From the French Claims Database

    Dec 1, 2023, 00:00

  • HTA178 Using Mixed-Methods Development-Focused HTA and Npv Calculations to Guide Further Investment and RD: A Case Study on Establishing the Value Proposition for Biosensor-Integrated Self-Reporting Arteriovenous Grafts

    Dec 1, 2023, 00:00

  • SA68 Consistency Between Network Meta-Analysis and Real-Word Data Analysis: Comparison of Changes in Hemoglobin A1c Levels After Treatment with Metformin Vs the Other Oral Antidiabetics in Japanese Patients with Type 2 Diabetes

    Dec 1, 2023, 00:00

  • PCR191 Assessing Quality of Care in Haemophilia Using a Value-Based Healthcare Approach

    Dec 1, 2023, 00:00

  • EE408 Pharmacoeconomic Analysis of Abrocitinib in Patients with Severe Atopic Dermatitis Versus Systemic Treatments in Spain

    Dec 1, 2023, 00:00

  • MT43 Does Real-World Evidence Play a Role in Decision-Making by HTA Bodies for Medical Technologies?

    Dec 1, 2023, 00:00

  • OP8 A New Complement Inhibitor: Impact of Ravulizumab on Eculizumab and Future Biosimilars Use, and Role of Paris Public Hospitals (AP-HP)

    Dec 1, 2023, 00:00

  • HPR90 Global Disparities in P4P Programs for Diabetes Care: A Comprehensive Analysis

    Dec 1, 2023, 00:00

  • SA79 Opportunities and Challenges for Decentralized Clinical Trials: European Health Technology Assessment Perspective

    Dec 1, 2023, 00:00

  • MSR37 Validation of the Ibadan Knee/Hip Osteoarthritis Outcome Measure (IKHOAM) Among Patients With Knee Osteoarthritis

    Dec 1, 2023, 00:00

  • HTA256 Identifying Current ATMP Market Access Challenges and Strategies in France, Germany, Italy, and Spain

    Dec 1, 2023, 00:00

  • EE732 Cost-Effectiveness Analysis of Strategies of Autologous Stem-Cell Transplantation and Maintenance Therapy for Transplant-Eligible Multiple Myeloma in China

    Dec 1, 2023, 00:00

  • HTA235 Comparative Narrative Review of Oncology Value Assessment Frameworks: Enfortumab Vedotin (EV) for Treatment of Locally Advanced or Metastatic Urothelial Carcinoma (la/mUC)

    Dec 1, 2023, 00:00

  • PCR54 Knowledge, Attitudes and Practices of Patients Towards Generics in Greece

    Dec 1, 2023, 00:00

  • HSD4 Institutional and Geographical Variation in Discharge Destination Among Admission Avoidance Municipal Inpatient Acute Care Units in Norway

    Dec 1, 2023, 00:00

  • CO99 Real-Life Effectiveness of Ibrutinib in Chronic Lymphocytic Leukemia

    Dec 1, 2023, 00:00

  • MSR124 Improving the Efficiency of Using the Guyot Algorithm to Construct Pseudo Individual Patient Data From Kaplan-Meier Survival Curves: Standardized Guidance and Data Preparation

    Dec 1, 2023, 00:00

  • EPH260 Rare Diseases and Kidney Stones: Are Stones in Amino Acid Transport Disorders Special?

    Dec 1, 2023, 00:00

  • EE52 Evaluation of the Economic Impact of Initial Diagnostic Modality Selection for Patients Suspected of Having Colorectal Cancer Liver Metastases or Hepatocellular Carcinoma in the UK

    Dec 1, 2023, 00:00

  • EE277 Assessing the Cost-Effectiveness of Semaglutide 2.4 Mg Injection for Chronic Weight Management in Portugal

    Dec 1, 2023, 00:00

  • HTA243 Guidelines for Incorporating the Societal Perspective and Wider Societal Benefits in Health Technology Assessment

    Dec 1, 2023, 00:00

  • RWD143 Beyond Accuracy: Automated De-Identification of Large Real-World Clinical Text Datasets

    Dec 1, 2023, 00:00

  • SA72 Current Practices for the Selection of Effect Modifiers and Confounders in Population-Adjusted Indirect Comparisons (PAIC): A Review of Technology Appraisals (TA)

    Dec 1, 2023, 00:00

  • EE751 Economic Evaluation of Hepatitis B Vaccination Programme in Finland

    Dec 1, 2023, 00:00

  • HPR217 Stakeholders' Perspectives on the Unmet Medical Need Concept: A EU Pharmaceutical Strategy Survey Analysis

    Dec 1, 2023, 00:00

  • PCR83 Fibrodysplasia Ossificans Progressiva (FOP): The Patient Experience

    Dec 1, 2023, 00:00

  • SA42 Project SATURN – A Real-World Evidence and Data Collaboration With Existing European Datasets in Osteogenesis Imperfecta to Support Future Therapies

    Dec 1, 2023, 00:00

  • EE243 Utilization of Healthcare Resources and Costs of Hemolytic Disease of Fetus and Newborn (HDFN) in Israel

    Dec 1, 2023, 00:00

  • SA47 Exploring the Use of Health Technology Assessment in Uganda’s Health Policy and Financing Decision-Making Processes

    Dec 1, 2023, 00:00

  • EPH132 Epidemiology of Breast and Cervical Cancer in Women of the Colombian Caribbean Region During 2018-2021

    Dec 1, 2023, 00:00

  • EE676 Cost Considerations: Exploring the Economic Implications of Choosing SC or IV Administration

    Dec 1, 2023, 00:00

  • EPH22 Mean Time on Triptan Treatment Among Danish Migraine Patients Before Discontinuing Treatment—A Register-Based Study

    Dec 1, 2023, 00:00

  • EPH254 Changes in Asthma-Related Healthcare Resource Use in Asthma Patients in the United States During the COVID-19 Pandemic

    Dec 1, 2023, 00:00

  • PT4 Patient-Reported Outcomes (PROs) in German AMNOG-Assessments: Impact of Increasing the Response Threshold to 15 %

    Dec 1, 2023, 00:00

  • EPH243 Overview of Lung Cancer Screening Studies in France and Bordering Countries

    Dec 1, 2023, 00:00

  • Comparative Efficacy of Venetoclax-Based Combination Therapies and Other Therapies in Treatment-Naive Patients With Acute Myeloid Leukemia Ineligible for Intensive Chemotherapy: A Network Meta-Analysis

    Dec 1, 2023, 00:00

  • HSD97 Exploring European Expert Opinion to Ensure Provision Outcomes in a Post-COVID World

    Dec 1, 2023, 00:00

  • MSR52 Defining Severity Category Thresholds to Guide Psoriasis Symptoms and Impacts Measure Score Interpretation Using Pooled Data from Three Phase 3 Trials in Plaque Psoriasis

    Dec 1, 2023, 00:00

  • HTA338 Characterization of the Evidence Supporting the Relative Effectiveness Evaluations in Health Technologies Assessment: A Review

    Dec 1, 2023, 00:00

  • RWD102 The Real-World Effectiveness of Tixagevimab and Cilgavimab in Immunocompromised Patients: A Single Center Study in Taiwan

    Dec 1, 2023, 00:00

  • HTA47 An Overview of the Challenges in the HTA of Interventions Involving Healthcare Reorganisation

    Dec 1, 2023, 00:00

  • CO146 Language Model-Based Approach for Extracting Comorbidities and Complications in Fabry Disease Clinical Notes

    Dec 1, 2023, 00:00

  • EE696 Economic and Clinical Burden Associated with Respiratory Syncytial Virus (RSV) and Expected Impact of Universal Immunization with Nirsevimab Among All Infants in Their First Rsv Season Against Standard of Care in Italy

    Dec 1, 2023, 00:00

  • EE185 Economic Burden of Chlamydia Trachomatis: A Targeted Literature Review and Gap Analysis

    Dec 1, 2023, 00:00

  • SA12 Discrepancy of Health State Utility Values in Cost-Utility Analyses of Interventions Against Infectious Diseases in Older Adults

    Dec 1, 2023, 00:00

  • HTA211 Requirements for Economic Evaluations for Health Technology Assessment Submissions across Different Countries

    Dec 1, 2023, 00:00

  • HSD35 Treatment and Dosage Patterns of Oral Corticosteroids Among Patients With Myasthenia Gravis: A Tale of Two Countries

    Dec 1, 2023, 00:00

  • MT71 Modelling the Value of Integrating Digital Cellular Pathology in the United Kingdom

    Dec 1, 2023, 00:00

  • HSD129 Does Digital Healthcare Improve the Utilization of Public Hospitals in the Emirate of Dubai?

    Dec 1, 2023, 00:00

  • PCR258 Baseline Demographic and Clinical Characteristics of Patients with Plaque Psoriasis Treated with Brodalumab in the Canadian Real-World Setting: Results from the Care Study

    Dec 1, 2023, 00:00

  • EE248 Evolution in Price Levels of Orphan Medicinal Products (OMP): Looking Back at the Past Decade

    Dec 1, 2023, 00:00

  • EPH28 Burden of Chronic Lymphocytic Leukemia in the United States: A Review of Literature

    Dec 1, 2023, 00:00

  • SA29 Evaluating the Adherence to ISPOR Guidelines in Globally Published Budget Impact Analyses of New Drugs: A Targeted Literature Review

    Dec 1, 2023, 00:00

  • HTA7 Exploring the Predictive Accuracy of Treatment Waning Methods: An Analysis of Pembrolizumab across Six Oncology Indications

    Dec 1, 2023, 00:00

  • HTA82 Surrogate Measures and the Health Technology Assessment of Cancer Drugs in Ireland: A Retrospective Analysis of EMA Cancer Drug Indication Approvals Between 2017 and 2022 and Recommendations Made By the NCPE in Ireland

    Dec 1, 2023, 00:00

  • CO24 Daratumumab in Combination with Lenalidomide and Dexamethasone Improves Survival in Newly Diagnosed Transplant-Ineligible Multiple Myeloma: A Parametric Network Meta-Analysis in a United Kingdom Setting

    Dec 1, 2023, 00:00

  • HTA97 Exploring the Value of RWD Collected From Early Access Programs to Support HTA Decision-Making

    Dec 1, 2023, 00:00

  • EE236 The Economic Impact of Third Line Chronic Phase Chronic Myeloid Leukemia Treatment in Greece From a National Payer Perspective

    Dec 1, 2023, 00:00

  • HSD66 Treatment Pathway and Unmet Needs of Waldenström Macroglobulinemia: An Exploratory Study from Portugal

    Dec 1, 2023, 00:00

  • HTA139 Uptake of Early Heath Technology Assessment in the United Kingdom: A Literature Review of Empirical Studies

    Dec 1, 2023, 00:00

  • EPH201 Epidemiology of Actinic Keratosis in Fran A General Population Survey (REAKT STUDY)

    Dec 1, 2023, 00:00

  • PCR78 Establishing Meaningful Change Thresholds for EORTC QLQ-CLL17 Domain Scores: An Analysis Based on the TRANSCEND CLL 004 Study in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

    Dec 1, 2023, 00:00

  • EE77 The Cost-Effectiveness of Tradition Chinese Medicine Icaritin Versus Cinobufotalin in Patients with Unresectable Advanced Hepatocellular Carcinoma in China

    Dec 1, 2023, 00:00

  • HSD15 Investigating the Impact of Early Versus Late Diagnosis in Fabry Disease on Healthcare Resource Utilization and Associated Costs in Greece

    Dec 1, 2023, 00:00

  • RWD21 Impact of Haemophilia Severity on Healthcare Resource Usage: Results from a Multinational Real-World Survey

    Dec 1, 2023, 00:00

  • HTA65 Economic Evaluation of Medical Devices By the French National Authority (2014-2022): Where Do We Stand?

    Dec 1, 2023, 00:00

  • EPH57 The Market Dynamics of GP IIb/IIIa Inhibitors in Germany: A Closer Look at Eptifibatide and Aggrastat

    Dec 1, 2023, 00:00

  • MT9 The Role of HTA Agencies in Relation to Medical Technologies: A Discourse Analysis

    Dec 1, 2023, 00:00

  • PCR273 Perceptions, Attitudes, and Satisfaction with Private Pharmacies in Gree Results from a Nationwide Survey

    Dec 1, 2023, 00:00

  • EE76 End-of-Life Cost and Characteristics of Acute Myeloid Leukemia Decedents: A National Study From 2011-2020

    Dec 1, 2023, 00:00

  • EPH270 Impacts of Different SARS-CoV-2 Variants on Hospital Usage and Performance in the United Arab Emirates: A Comparison Among Alpha, Delta, and Omicron

    Dec 1, 2023, 00:00

  • HTA106 What Are the Main Drivers for Decision-Making Regarding the Incorporation of a Healthcare Technology By CONITEC in Brazil? A Study in the Cardiovascular, Oncology, and Respiratory Fields

    Dec 1, 2023, 00:00

  • HTA255 First-in-Class Drugs in HTA: Blunder or Bliss?

    Dec 1, 2023, 00:00

  • HTA118 Estimands in Health Technology Assessments: Methodological Considerations and Recommendations

    Dec 1, 2023, 00:00

  • HPR42 A Review of Approved Managed Entry Agreements in Sweden

    Dec 1, 2023, 00:00

  • EE680 Axicabtagene Ciloleucel as Second-Line Treatment for Relapsed/Refractory Large B-Cell Lymphoma in Spain: A Cost-Effectiveness Analysis

    Dec 1, 2023, 00:00

  • EPH46 Validation of Dynamic Transmission Model for Varicella Immunization Program in Germany

    Dec 1, 2023, 00:00

  • MT51 Does Current Reimbursement Drive the Adoption of Computer-Aided Applications to Increase the Adenoma Detection in Colonoscopies – a Provider-Based Impact Model for Germany, France, and Italy

    Dec 1, 2023, 00:00

  • HTA168 Widening the Value Lens for Child Health Technologies: Development of a Child-Tailored HTA Value Assessment Framework Using Multi-Criteria Decision Analysis Incorporating Patient, Public, and Expert Perspectives

    Dec 1, 2023, 00:00

  • HSD43 Survey Research Using PRO Data in Clinical Practi Lessons Learnt from the Nordic Countries

    Dec 1, 2023, 00:00

  • EE168 A Markov Model to Determine the Cost-Effectiveness of a Multi-Targeting Bacterial Gene Therapy (AUP-16) at Healing a Diabetic Foot Ulcer When Compared to the Current Standard of Care

    Dec 1, 2023, 00:00

  • EE297 Healthcare Resources Utilization Among Sectors in Saudi Arabia

    Dec 1, 2023, 00:00

  • EE383 Cost-Effectiveness Analysis of Nivolumab Plus Relatlimab (NIVO+RELA) Versus Nivolumab Monotherapy (NIVO) for Patients With Advanced Melanoma in the Netherlands

    Dec 1, 2023, 00:00

  • EE636 Cost-Minimization Analysis of Delafloxacin Versus Standard of Care for the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) in Jordan

    Dec 1, 2023, 00:00

  • P32 Implementation of Early Access Reform in France and Access to Innovation: Impact in Terms of Number of Drugs, Patients Treated, and Cost

    Dec 1, 2023, 00:00

  • EE294 Public Health Impact and Cost-Effectiveness of Recombinant Zoster Vaccination Among 50 Years Old or Older in Austria

    Dec 1, 2023, 00:00

  • EE634 Resource Utilization and Costs Related to Inflammatory Bowel Disease: A Longitudinal Analysis Based on Routine Data from Two German Statutory Health Insurance Providers

    Dec 1, 2023, 00:00

  • EPH191 Iron Deficiency Anemia Is Associated with Colorectal and Stomach Cancer Diagnoses in Germany

    Dec 1, 2023, 00:00

  • EPH250 Clinical Characteristics of Generalized Pustular Psoriasis Flares in the Real-World Setting

    Dec 1, 2023, 00:00

  • EE267 Cost-Effectiveness of a Web-Based Interactive Therapeutic Education Platform: Evidence From a Randomized Clinical Trial for Patients With End-Stage Renal Disease

    Dec 1, 2023, 00:00

  • EE462 Same Day Discharge after Percutaneous Transluminal Coronary Angioplasty (PTCA): Is It Cost Saving?

    Dec 1, 2023, 00:00

  • HTA21 A Retrospective Review of Recent NICE Technology Appraisals From 2021 to 2023 to Investigate the Consideration and Acceptability of Cure Modelling Assumptions

    Dec 1, 2023, 00:00

  • P48 New NICE Proportionate Approaches: Are They Any Faster or More Successful?

    Dec 1, 2023, 00:00

  • EE103 Cost-Effectiveness Analysis of Single-Inhaler Triple Therapy (FF/UMEC/VI) in COPD Using the Fulfil Trial: China Medical Insurance System Perspective

    Dec 1, 2023, 00:00

  • RWD73 Exposing the True Economic Impact of Stroke: A Comparative Analysis of Time-Driven Activity-Based Costing and Reimbursement Methods in Brazil

    Dec 1, 2023, 00:00

  • EPH10 ICD-10 Surrogates of the Modified Frailty Index Predict Hospital Referrals in Outpatients Followed in German General Practices

    Dec 1, 2023, 00:00

  • HTA253 Analysis of HTA Assessments, Usage, and Reimbursement of Newly Introduced Outpatient Drugs in the Netherlands Between 2017 and 2021 – A Secondary Data Analysis

    Dec 1, 2023, 00:00

  • HSD67 How Can a Digital Twin Help Achieve Technical Efficiency? an Application to the French Medical Genomics Pilot Sequencing Platform Auragen

    Dec 1, 2023, 00:00

  • CO92 Clinician-Reported Outcome Measure for Palonosetron Versus Standard of Care in Chemotherapy-Induced Nausea and Vomiting in Egypt

    Dec 1, 2023, 00:00

  • EE693 Assessing the Impact of Additional Follow-up From the CheckMate-274 Trial on the Cost-Effectiveness (CE) Profile of Nivolumab Versus Surveillance in High-Risk, Muscle-Invasive Urothelial Carcinoma (MIUC)

    Dec 1, 2023, 00:00

  • HPR140 Quantifying the Impact of Novel Anti-Cancer Therapies on Health Inequalities in Survival Based on Kaplan-Meier Curves

    Dec 1, 2023, 00:00

  • CO102 Physician Reported Treatment Attributes Considered in First-Line and Perceptions Around Bruton Tyrosine Kinase Inhibitor (BTKi) Treatments in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) in the US

    Dec 1, 2023, 00:00

  • PCR12 Construct Validity of a New Migraine Satisfaction with Treatment Questionnaire

    Dec 1, 2023, 00:00

  • EPH149 Prevalence, Burden of Disease, and Treatment Patterns of Vitiligo in Patients Across European Countries

    Dec 1, 2023, 00:00

  • EE90 Clinical Manifestations and Disease Burden of Primary Mitochondrial Myopathies (PMM): Results from a Patient Journey Analysis Show Substantial Healthcare Resource Utilization

    Dec 1, 2023, 00:00

  • HTA30 Behavioural Structured Expert Elicitation: A Case Study to Inform Hospitalisation Due to Respiratory Syncytial Virus in the UK

    Dec 1, 2023, 00:00

  • HTA318 Delays in NICE Highly Special Technology (HST) Appraisal for Medicines That Treat Ultra-Orphan Conditions

    Dec 1, 2023, 00:00

  • CO158 Analysis of Clinical Endpoints in Clinical Trials for NAFL and NASH: A Comprehensive Review

    Dec 1, 2023, 00:00

  • RWD97 Systematic Identification, Access, and Utility Mapping of Asia Pacific Real-World Data Sources for Rare and Non-Rare Retinal Diseases

    Dec 1, 2023, 00:00

  • EE346 Evaluating the Economic Burden of Osteoporosis in the United States: Insights from a MEPS-Based Analysis

    Dec 1, 2023, 00:00

  • RWD30 Applying Transportability Methods to Real-World Data: A Scoping Review

    Dec 1, 2023, 00:00

  • RWD161 Identifying and Characterizing Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) Population in Finland

    Dec 1, 2023, 00:00

  • EE118 Cost Incurred Post-Kidney Transplant: A Systematic Review

    Dec 1, 2023, 00:00

  • EE27 Risk, Use, and Cost of Infection-Related Hospitalization of Individuals With Alzheimer’s Disease or Dementia

    Dec 1, 2023, 00:00

  • CO159 A Bayesian Network Meta-Analysis (NMA) for Evaluating the Relative Efficacy of Dual Therapy Combinations of Dapagliflozin and Metformin in Patients With Type 2 Diabetes Mellitus (T2DM)

    Dec 1, 2023, 00:00

  • EPH205 Inside CKD: Predicting the Clinical and Economic Burden of Chronic Kidney Disease in Belgium

    Dec 1, 2023, 00:00

  • MSR74 The Use of Matching-Adjusted Indirect Comparison for Oncology Submissions in NICE

    Dec 1, 2023, 00:00

  • EE621 Cost-Effectiveness Analysis of iGlarLixi Compared With Basal Bolus Insulin Regimen in Triple Metabolic Goal in Type 2 Diabetes Mellitus in Latin America

    Dec 1, 2023, 00:00

  • HTA203 Identification and Comparison of HTA Tools Suitable for Low- and Middle-Income Countries

    Dec 1, 2023, 00:00

  • EPH176 Comorbidities Among Individuals at Risk to Develop Severe Form of COVID-19 in Case of Sars-Cov-2 Infection

    Dec 1, 2023, 00:00

  • EE284 A Qualitative Primary Market Research Study on the Economic Investment of Scaling up Bariatric Surgery Capacity Within the NHS

    Dec 1, 2023, 00:00

  • RWD163 The Economic Burden of Cutaneous Malignant Melanoma in Gree Analysis of Real-Word Health Insurance Data

    Dec 1, 2023, 00:00

  • HPR195 Market Access Implications of Early Access to Medicines Scheme in the UK

    Dec 1, 2023, 00:00

  • PT23 Is It Possible to Estimate the Welfare Economic Loss to Society of Not Having Value-Based Differential Pricing for Multi-Indication Pharmaceuticals: An Empirical Analysis in Denmark, Norway, and Sweden

    Dec 1, 2023, 00:00

  • CO110 Systematic Literature Review and Network Meta-Analysis to Assess the Comparative Efficacy of Topical Fixed-Dose Combinations for Moderate to Severe Acne Vulgaris as Measured By Lesion Counts

    Dec 1, 2023, 00:00

  • RWD140 Quality of Electronic Health Records: Encountering Misclassification

    Dec 1, 2023, 00:00

  • HTA274 Similarities and Differences in Health Technology Assessment (HTA) Bodies Considerations for Decision-Making: Use of Patient Preference Studies

    Dec 1, 2023, 00:00

  • MT33 Cost-Effectiveness Analysis of Watchman FLX Left Atrial Appendage Closure in Patients with Non-Valvular Atrial Fibrillation

    Dec 1, 2023, 00:00

  • HPR60 Voluntary Scheme for Branded Medicines Pricing and Access vs Statutory Scheme: A Case of Six vs Half a Dozen?

    Dec 1, 2023, 00:00

  • EE666 Cost-Effectiveness of Duvelisib Versus the Bendamustine Plus Rituximab Regimen for Relapsed/Refractory Follicular Lymphoma Patients in China

    Dec 1, 2023, 00:00

  • EE231 Model-Based Assessment of the Costs and Benefits of Directly Mailing Self-Sampling HPV Kits to Non-Participants in Cervical Screening in the Czech Republic

    Dec 1, 2023, 00:00

  • HTA56 Unequal Access of Innovative Drug Products Across Canada

    Dec 1, 2023, 00:00

  • HPR185 The Influence of Value Frameworks on Payer and Oncologist Decision-Making in the United States (US)

    Dec 1, 2023, 00:00

  • PCR244 Core Oncology Outcome Strategies: Do They Offer an Opportunity for Simplicity and Consistency, or Pose a Risk to Comprehensive Understanding of Patient Experiences?

    Dec 1, 2023, 00:00

  • RWD103 NVX-CoV2373 Patient Characteristics in Germany: Real-World Retrospective Database Study Shows Most Vaccine Recipients Were Among the High Risk Category

    Dec 1, 2023, 00:00

  • MSR55 How Different Are EQ-5D-Y Values in Asia? a Comparison Study of Four Jurisdictions

    Dec 1, 2023, 00:00

  • HTA99 Expert Validation on Proposed Framework for Differentiated HTA Criteria for Rare Disease Drugs in Brazil

    Dec 1, 2023, 00:00

  • EPH101 Assessing the Relative Benefits Associated With Developing Vaccines for Nipah Virus Infection and Rift Valley Fever From Local, National, and Global Perspectives

    Dec 1, 2023, 00:00

  • EE244 Healthcare Resource Utilization and Costs in Patients with Alagille Syndrome Using Population-Based Healthcare Data from South Korea

    Dec 1, 2023, 00:00

  • EE625 Time in Range As Alternative to HBA1C Change in the IQVIA Core Diabetes Model

    Dec 1, 2023, 00:00

  • EPH221 Age, Sex, and Comorbidity Differences Between Patients with Mild and Severe Aortic Stenosis in German Cardiology Practices

    Dec 1, 2023, 00:00

  • EE78 A Cost-Effectiveness Analysis of Atezolizumab as Adjuvant Treatment Following Complete Resection and Platinum-Based Chemotherapy in Adult Patients With Early-Stage Non-Small Cell Lung Cancer With a High Risk of Recurrence

    Dec 1, 2023, 00:00

  • P16 What Trade-Offs Are Women Willing to Make When Choosing Between Potential Treatments for Moderate-to-Severe Vasomotor Symptoms Due to Menopause?

    Dec 1, 2023, 00:00

  • PCR162 Talking with Teens: Techniques for Building Rapport with Adolescents in Virtual Qualitative Interviews

    Dec 1, 2023, 00:00

  • CO147 Impact of COVID-19 on Patients With Asthma in US Routine Care

    Dec 1, 2023, 00:00

  • EE505 Cost-Effectiveness of Ofatumumab in Treatment of Relapsing Multiple Sclerosis in Turkey

    Dec 1, 2023, 00:00

  • P22 Disrupting Health Economics: Automating Network Meta-Analyses With AI and Large Language Models

    Dec 1, 2023, 00:00

  • EE191 Projecting Costs of Care Burden of Depression Between 2023 and 2032 in Hong Kong: A Time-Inhomogeneous Cohort Markov Model Using Real-World Evidence

    Dec 1, 2023, 00:00

  • Care Pathway Analysis to Inform the Earliest Stages of Technology Development: Scoping Oncological Indications in Need of Innovation

    Dec 1, 2023, 00:00

  • PCR18 Humanistic Burden in Relapsed or Refractory (R/R) Follicular Lymphoma (FL): A Systematic Literature Review (SLR)

    Dec 1, 2023, 00:00

  • MSR104 Deriving Caregiver Health Utilities from Patient Endpoints: A Predictive Modelling Approach Using Real-World Survey Data

    Dec 1, 2023, 00:00

  • HTA114 How Are Companion Diagnostics Evaluated and Reimbursed in Europe? Comparative Analysis of the EU-4 and UK

    Dec 1, 2023, 00:00

  • HPR54 Policy Approaches to the Regulation and Reimbursement of Pediatric Medicines: Comparing Canadian, European, and UK Health Systems

    Dec 1, 2023, 00:00

  • RWD50 Evaluation and Improvement of a NHDS Algorithm to Detect Patients With Metastatic Breast Cancer and HER2+ Status Using a RWE NLP-Powered Solution

    Dec 1, 2023, 00:00

  • HTA289 Optimizing Healthcare Outcomes: Identifying the Conditions for Successful Value-Based Contracts

    Dec 1, 2023, 00:00

  • EE340 Cost-Effectiveness Analysis of Molnupiravir Against Standard Care for Treating Mild to Moderate COVID-19 Infection in Singapore.

    Dec 1, 2023, 00:00

  • CO190 Cannabis-Based Formulations: Clinical and Economic Results Promising Savings and Sustainability

    Dec 1, 2023, 00:00

  • EE508 Cost Estimation Model of Prevented Recurrences with Atezolizumab in Early Non-Small Cell Lung Cancer in Italy

    Dec 1, 2023, 00:00

  • RWD34 Characterization and Trends of Non-Hypothesis Evaluating Treatment Effectiveness (Non-HETE) Studies

    Dec 1, 2023, 00:00

  • EE651 Incremental Cost per Remission in Patients With Rheumatoid Arthritis Who Had Inadequate Response to Conventional Synthetic Disease-Modifying Antirheumatic Drugs in Colombia

    Dec 1, 2023, 00:00

  • CO117 Prognostic Factors and Surrogate Endpoints in Obstructive Hypertrophic Cardiomyopathy: A Systematic Literature Review

    Dec 1, 2023, 00:00

  • MSR3 Comparing Statistical Adjustments to Correct Misclassification of Respiratory Syncytial Virus Infections (RSV) in Claims Data

    Dec 1, 2023, 00:00

  • HPR17 Exploring Heterogeneity in Biosimilars Dynamics in Italy: Results From Three Chronic Therapeutic Areas

    Dec 1, 2023, 00:00

  • RWD47 Non-Motor Symptoms Burden and Quality of Life in Patients with Parkinson’s Disease (PD)

    Dec 1, 2023, 00:00

  • EE92 Introduction to the Duchenne Muscular Dystrophy Burden-of-Illness Study Expanded (US AND SPAIN)

    Dec 1, 2023, 00:00

  • CO31 Progressive Pulmonary Fibrosis: A Modelling Analysis of Long-Term Progression Based on Inbuild

    Dec 1, 2023, 00:00

  • CO111 Clinical Efficacy and Safety of Interventions for Adult Patients With Moderately Severe to Severe Hemophilia B: A Systematic Review

    Dec 1, 2023, 00:00

  • EE377 Budget Impact Analysis of Implementing a Breast Cancer Screening Program in Bulgaria

    Dec 1, 2023, 00:00

  • EE728 Examining Hospital-Onset Urinary Tract Infection (HO-UTI) in Male Patients – Modeling the Economic Impact of Utilizing External Male Wicking Catheters (EMWCS)

    Dec 1, 2023, 00:00

  • EPH265 Updated Estimations of the HPV Vaccination Deficit Among Girls in Gree Early Signs of Recovery?

    Dec 1, 2023, 00:00

  • EPH92 The Development of an Interactive Visual Tool to Communicate the Burden of Atopic Dermatitis in Finland

    Dec 1, 2023, 00:00

  • EE206 Clinical and Economic Evaluation of Atezolizumab + Vemurafenib + Cobimetinib Combination in Treatment of Adult Patients with Metastatic Braf-Positive Melanoma

    Dec 1, 2023, 00:00

  • RWD139 Exploring Respiratory Syncytial Virus and Influenza Trends Pre- and Post-COVID-19 in the US and EU-5 Countries

    Dec 1, 2023, 00:00

  • OP20 Carer Health-Related Quality of Life in Health Technology Assessments: Process Recommendations for Determining Relevance, Data Collection, and Inclusion in Health-Economic Models

    Dec 1, 2023, 00:00

  • EE94 Current State of Health Economic Models in Hereditary Angioedema

    Dec 1, 2023, 00:00

  • HTA220 Incorporating Environmental Sustainability Considerations into National HTA Assessments: A Landscape Review

    Dec 1, 2023, 00:00

  • HTA327 Acceptance of Real-World Evidence As Comparative Efficacy in Lieu of Trial Eviden A Review of Past NICE Appraisals in Oncology

    Dec 1, 2023, 00:00

  • SA17 Application of CPRD Data in NICE Submissions: Model Inputs for Functional Health States

    Dec 1, 2023, 00:00

  • CO123 Long COVID Symptom Diary: Development of a PRO Instrument to Support Drug Development and Regulatory Submissions in Europe

    Dec 1, 2023, 00:00

  • HTA150 Health Technology Assessment of Domiciliary Invasive Ventilation for Adults With Spinal Cord Injuries

    Dec 1, 2023, 00:00

  • RWD39 Comparative Effectiveness and Health Resource Utilization of Xuesaitong Soft Capsule in Patients with Stroke of Secondary Prevention in China: A Retrospective Cohort Study

    Dec 1, 2023, 00:00

  • EE328 Healthcare Costs in Patients With Hepatic Encephalopathy Receiving Rifaximin-α Treatment in the IMPRESS-II Study

    Dec 1, 2023, 00:00

  • EE608 The Use of Vignette Studies to Estimate Health-State Preference in Sweden and Norway

    Dec 1, 2023, 00:00

  • HTA208 Paradigm Shift or Incremental Change? Real-World Evidence for Health Technology Assessment: A Critical Appraisal

    Dec 1, 2023, 00:00

  • HTA346 The Use of Real-World Evidence in Health Technology Assessment Decisions in Sweden and the UK: A Natural Language Processing (NLP) Approach

    Dec 1, 2023, 00:00

  • EE414 Incremental Costs of Abrocitinib Compared to Dupilumab for the Treatment of Moderate to Severe Atopic Dermatitis in Denmark

    Dec 1, 2023, 00:00

  • HTA237 Treatment Effect Waning in Immuno-Oncology Health Technology Assessments: A Review of Assumptions and Supporting Evidence

    Dec 1, 2023, 00:00

  • RWD77 Real-World Data Analysis Showing a Significant Improvement in Glycemic Control of People with T2D in Poland When Using a Blood Glucose Meter Connected to a Mobile Health App

    Dec 1, 2023, 00:00

  • PCR275 An Interpretive Phenomenological Analysis of Financial Toxicity in Indonesian Cancer Patients

    Dec 1, 2023, 00:00

  • SA24 Can an Integrated Systematic Literature Review (SLR) Database Improve the Speed of Title and Abstract (TIAB) Review? A Case Study Using Multiple Myeloma (MM) Projects in Interventional and Real-World Evidence (RWE) Evidence

    Dec 1, 2023, 00:00

  • EPH145 The Epidemiology of Asthma in Children Between 2004 and 2021 Using Livingstone: An Online, Automated Analytical Platform

    Dec 1, 2023, 00:00

  • HPR134 Ethical Considerations in Pay-for-Performance Programs for Diabetes

    Dec 1, 2023, 00:00

  • CO171 Associations of Sex and Race with Relative Efficacy in Clinical Trials

    Dec 1, 2023, 00:00

  • HTA71 Bridging the Gap: Exploring the PICO Vs Estimand Frameworks in EU Health Technology Assessment (HTA)

    Dec 1, 2023, 00:00

  • EE616 Cardiometabolic Disease Prevention Policy Models: A Systematic Review

    Dec 1, 2023, 00:00

  • HPR69 Comparison of Price Trends for Medicines Pre- and Post-Early Access in Key Markets (France, UK, Australia)

    Dec 1, 2023, 00:00

  • EE705 The Healthcare Resource Utilisation and Associated Costs for Patients with Newly Diagnosed Fragile X Syndrome

    Dec 1, 2023, 00:00

  • OP7 Coverage and Equity of a Patient Support Program for Diabetes During the Pandemic Period in a Middle-Income Country

    Dec 1, 2023, 00:00

  • MSR48 Using Bayesian Methodology to Minimize Control Recruitment in Trials of Relapsed and Refractory (RR) Multiple Myeloma (MM) Through Incorporation of Prior Control Response Information Borrowed From Real-World Evidence

    Dec 1, 2023, 00:00

  • EE411 Cost-per-Responder Analysis of Tralokinumab and Dupilumab in the Treatment of Moderate-to-Severe Atopic Dermatitis

    Dec 1, 2023, 00:00

  • The Relationship Between Pharmaceutical Innovation and Cancer Mortality in Spain, From 1999 to 2016

    Dec 1, 2023, 00:00

  • HTA104 Data on Patient-Reported Outcomes Is Not a Prerequisite for Achieving an Additional Benefit in German Early Benefit Assessment of New Medicinal Products Approved for Dermatological Diseases

    Dec 1, 2023, 00:00

  • HPR34 Analysis of Public Health Insurance Expenditures in Turkiye By SGK between 2020-2021-2022

    Dec 1, 2023, 00:00

  • How Do Patients With Type 2 Diabetes Mellitus Value the Importance of Outcomes? An Overview of Reviews

    Dec 1, 2023, 00:00

  • EPH24 Changes in Prescribing of Systemic Cancer Therapies in England: A Nationwide Analysis of Community and Hospital Medicines Utilisation

    Dec 1, 2023, 00:00

  • EPH161 Epidemiology Landscape and Impact of Obesity: Multi-Country Results from the Impact-O Study

    Dec 1, 2023, 00:00

  • EPH224 Temporal Trends of Percutaneous Transluminal Coronary Angioplasty Procedure and Mortality Rates in the Brazilian Public Healthcare: A Real World Data Analysis From 2014 to 2022

    Dec 1, 2023, 00:00

  • MSR111 Causal Inference and Statistical Considerations for Indirectly Comparing Time-to-Event Endpoints for Treatments with Different Starting Points for Outcome Assessment in Resectable NSCLC

    Dec 1, 2023, 00:00

  • MT72 Effectiveness of Drone Technology on Access to Blood and Its Product in the Eastern Region of Ghana: A Cross-Sectional Study

    Dec 1, 2023, 00:00

  • EPH125 A Systematic Literature Review and Meta-Analysis on the Disease Burden of Chikungunya

    Dec 1, 2023, 00:00

  • EE110 Economic Analysis of Sugammadex for Neuromuscular Block Reversal for Laparoscopic Surgery from a Single Hospital System in China

    Dec 1, 2023, 00:00

  • HTA351 A Targeted Review Exploring How English and German Health Technology Assessment Agencies Differ in Their Appraisal of Digital Health Apps

    Dec 1, 2023, 00:00

  • EPH31 Systematic Literature Review on the Global Epidemiology of Angelman Syndrome

    Dec 1, 2023, 00:00

  • EPH196 Prevalence of GI Comorbidities by Age Group Among Patients With Rett Syndrome: An Analysis of Coded EHR and Pharmacy Data and Clinical Notes

    Dec 1, 2023, 00:00

  • EE574 Cost-Effectiveness Analysis of Difelikefalin for Patients with Chronic Kidney Disease-Associated Pruritus (CKD AP) Undergoing Haemodialysis in Italy

    Dec 1, 2023, 00:00

  • CO132 A Real-World Evidence Analysis of the Impact of Patient-Physician Sex Concordance on Cancer Treatment Practices and Outcomes

    Dec 1, 2023, 00:00

  • EE422 Health Economic Modelling of Current Population Health Management Interventions for CKD in the UK Using a Population-Level Markov Model

    Dec 1, 2023, 00:00

  • Reflecting Parameter Uncertainty in Addition to Variability in Constrained Healthcare Resource Discrete Event Simulations: Worth Going the Extra Mile or a Road to Nowhere?

    Dec 1, 2023, 00:00

  • EE101 Assessing the Cost-Effectiveness of Introducing Benralizumab in the Treatment of Severe Uncontrolled Eosinophilic Asthma Patients in Prince Sultan Military Medical City (PSMMC) - Kingdom of Saudi Arabia (KSA)

    Dec 1, 2023, 00:00

  • HPR86 Reducing Inequity: Does the New EU Pharmaceutical Legislation Address Challenges to Pharmaceutical Access in Central and Eastern Europe?

    Dec 1, 2023, 00:00

  • MSR120 A Method for Adjusting US Health State Utilities for Use in the UK

    Dec 1, 2023, 00:00

  • HPR169 The Impact of Exercise on Health Expenditure in Children

    Dec 1, 2023, 00:00

  • EE315 The Budget Impact of Including the Automated Time-Resolved Fluorescence Immunoassay As Point-of-Care Testing on Cardiac Markers in an Emergency Department in China

    Dec 1, 2023, 00:00

  • EPH87 Real-World Evidence Study on Hemophilia B Treatment with Factor IX and Corresponding Treatment Costs in Finland

    Dec 1, 2023, 00:00

  • EE721 Ferric Carboxymaltose in the Treatment of Iron Deficiency Anemia in Patients with Pregnancy, Inflammatory Bowel Disease, Heart Failure and Bariatric Surgery Under the Payer’s Perspective of the Supplementary System in Brazil

    Dec 1, 2023, 00:00

  • EE188 A Retrospective Cohort Comparing the Tuberculosis Diagnosis Related Costs and Health Resource Use (HRU) Using a Rapid Nucleic Acid Amplification (NAA) Test Vs. Conventional Tests in China, Followed By a Budget Impact Model

    Dec 1, 2023, 00:00

  • An Intersectional Approach to Quantifying the Impact of Geographic Remoteness and Health Disparities on Quality-Adjusted Life Expectancy: Application to Australia [Editor's Choice]

    Dec 1, 2023, 00:00

  • EE420 Cost-Effectiveness of Empagliflozin in Chronic Kidney Disease (CKD) Management in the UK

    Dec 1, 2023, 00:00

  • EPH56 The Impact of the COVID-19 Pandemic on Cardiovascular Disease Prevention and Corresponding Geographical Inequalities in England: Interrupted Time Series Analysis

    Dec 1, 2023, 00:00

  • EPH248 Varying Latency Impact on Incidence of Second Primary Malignancy Among Patients with B-Cell Malignancy

    Dec 1, 2023, 00:00

  • MT48 Digital Health Technologies: Challenges in Evaluating Same ‘Class’ of Technologies

    Dec 1, 2023, 00:00

  • PCR118 Cross-Sectional Measurement Properties of the Physical Distancing Scale – COVID-19 (PDS-C19) Self- and Observer-Reported Measure of Physical Distancing Behaviors to Avoid COVID-19 in Adults, Children, and Caregivers

    Dec 1, 2023, 00:00

  • MSR33 Improving Analysis of Continuous Predictors: Advantages of Fractional Polynomial Transformations (FP) and Interpretation of “Non-Linear” Odds Ratios (OR) or Hazard Ratios (HR)

    Dec 1, 2023, 00:00

  • EE292 Cost Effectiveness Analysis of Recombinant Zoster Vaccine Among 50 Years Old and Older in Sweden

    Dec 1, 2023, 00:00

  • HPR209 Criteria for Decision-Making on Drug Financing in Spain: How Do We Measure Them and What Relevance Does Each One Have?

    Dec 1, 2023, 00:00

  • P38 Forecasting Emergency Department Waiting Times Using Deep Neural Networks

    Dec 1, 2023, 00:00

  • MT23 Hypoglossal Nerve Stimulation in Obstructive Sleep Apnea: A Systematic Literature Review

    Dec 1, 2023, 00:00

  • RWD122 First and Second Line Treatment Choices for Endometrial Cancer: ECHOS-A Real-World Study

    Dec 1, 2023, 00:00

  • EE759 Willingness-To-Pay for a QALY: A New Approach to Estimate Cost-Effectiveness Threshold Applied to France

    Dec 1, 2023, 00:00

  • HSD44 Healthcare Resource Utilization of Severe Eosinophilic Asthma Patients Treated With Benralizumab in Real-Life: Results From the Portuguese BETREAT Study

    Dec 1, 2023, 00:00

  • EPH37 Burden of Disease and Cost of Illness of Age Related Macular Degeneration and Diabetic Macular Edema in Portugal

    Dec 1, 2023, 00:00

  • P7 International Reference Pricing and Joint Clinical Assessments—How Will European-Level HTA Evaluations Impact International Reference Pricing and Launch Sequencing?

    Dec 1, 2023, 00:00

  • HSD116 Actual Use in Real World Setting of Anti-BCMA CAR T Cells in Relapsed/Refractory Multiple Myeloma in EU5 Countries and in the US

    Dec 1, 2023, 00:00

  • CO87 Lifetime Cumulative Risk of Bone Fracture in Chinese Male Patients with Osteoporosis: A Model Simulation Study

    Dec 1, 2023, 00:00

  • EPH273 Using Real-World Data Sources in England to Quantify the Burden of Non-Alcoholic Steatohepatitis

    Dec 1, 2023, 00:00

  • PCR41 The Impact of Moderate to Severe Chronic Hand Eczema and the Effect of Improved Clinical Symptoms on Work Productivity Loss: Data from the DELTA 1 and DELTA 2 Phase 3 Trials

    Dec 1, 2023, 00:00

  • RWD78 Hospitalization Costs for Patients with Acute Appendicitis: An Update Using Real-World Data from a Large Province in China

    Dec 1, 2023, 00:00

  • MSR8 Nesting a Decision Tree into a Markov Model Structure: An Alternative Way of Tracking Movement in a Diagnostic Model

    Dec 1, 2023, 00:00

  • EE131 Genetic-Guided Pharmacotherapy for Cardiovascular Disease: A Systematic and Critical Review of Economic Evaluations

    Dec 1, 2023, 00:00

  • CO100 Regular Laboratory Checks for Ileostomy Patients After Surgery Are Not Performed Comprehensively, but Could Result in Better Health Outcomes

    Dec 1, 2023, 00:00

  • EE506 RNA Interference Therapies for hATTR Amyloidosis With Polyneuropathy: Differential Healthcare Resource Use and Direct and Indirect Cost Consequences Associated With Vutrisiran Versus Patisiran

    Dec 1, 2023, 00:00

  • MSR146 Proportional Hazards in Survival Analysis: A Review of the Variation in Determining and Presenting PH in NICE STAs

    Dec 1, 2023, 00:00

  • PCR31 Psychometric Performance of the Functional Assessment of Chronic Illness Therapy (FACIT) Fatigue Questionnaire Among Patients With Paroxysmal Nocturnal Hemoglobinuria

    Dec 1, 2023, 00:00

  • MT18 Endovascular Management of Iliac and Aorto-Iliac Aneurysms and Impact on Morbidity/Mortality in Fran A French National Insurance Claims Database Analysis (SNDS)

    Dec 1, 2023, 00:00

  • EPH128 Evaluation of the Effects of the COVID-19 Pandemic on Depression Among the Under 20-Year-Old Population in Japan, the US, and Germany Before and During the COVID-19 Pandemic: A Retrospective Observational Study Using Real-World Data

    Dec 1, 2023, 00:00

  • HTA158 Exploring Efficiency of Living Systematic Literature Review (SLR) Tool for Submissions of Clinical Evidence to National Institute for Health and Care Excellence (NICE) by Combining Interventional and Real-World Evidence (RWE)

    Dec 1, 2023, 00:00

  • HPR110 From Paper to Patients: Revealing the Impact of the United Kingdoms' (UK) Health Technology Assessment (HTA) Policies on Advanced Therapy Medicinal Products (ATMPS)

    Dec 1, 2023, 00:00

  • RWD120 Analysis of the Impact of National Medical Insurance Negotiation Policy on the Accessibility of Anti-Cancer Drugs in a City in China

    Dec 1, 2023, 00:00

  • PCR20 Preferences for Cancer Treatments: A Discrete-Choice Experiment with Adult Patients with Cancer in Europe

    Dec 1, 2023, 00:00

  • EE678 Time and Cost Savings from Adopting an Alternative Dosing Schedule with Pembrolizumab for Patients with Advanced Melanoma in Greece

    Dec 1, 2023, 00:00

  • EE217 Cancer-Related Mortality in Turkiye: Years of Life Lost and Productivity Costs

    Dec 1, 2023, 00:00

  • HTA352 The Significance of Literature Reviews in the Process of Decision-Making by the Haute Autorité De Santé

    Dec 1, 2023, 00:00

  • EE286 Cost Effectiveness and Public Health Impact of Implementing Gender-Neutral Vaccination with the 9-Valent Human Papillomavirus Vaccine in Turkiye

    Dec 1, 2023, 00:00

  • CO12 5 Years of Real-World Data on the Use of Cladribine Tablets for the Treatments of Multiple Sclerosis in Portugal

    Dec 1, 2023, 00:00

  • MSR39 The Performance of Anchored and Unanchored Population Adjustment Methods (MATCHING-ADJUSTED INDIRECT COMPARISON, SIMULATED TREATMENT COMPARISON, AND MULTIPLE IMPUTATION MARGINALIZATION) in Castration Resistant Prostate Cancer

    Dec 1, 2023, 00:00

  • EE254 Budget Impact of Telemonitoring (TM)-Enabled Care of Obstructive Sleep Apnea Hypoanpnea Syndrome (OSAH) in the UK

    Dec 1, 2023, 00:00

  • HTA331 Health Technology Assessment of Point-of-Care Diagnostics for Antimicrobial Resistance; Perspectives and Recommendations from an Expert Advisory Panel

    Dec 1, 2023, 00:00

  • EPH9 Non-Alcoholic Fatty Liver Disease Awareness in the United States: National Health and Nutrition Examination Survey Data 1999-2020

    Dec 1, 2023, 00:00

  • RWD58 Impact of Bleeds on the Quality of Life of Patients with Haemophilia: Results from a Multinational Real-World Survey

    Dec 1, 2023, 00:00

  • HPR202 The Digital Transformation: How Could Artificial Intelligence (AI) Re-Shape Drug Launch?

    Dec 1, 2023, 00:00

  • OP12 Adherence to Intravenous to Oral Switching Criteria in a Tertiary Governmental Hospital in Riyadh, Saudi Arabia

    Dec 1, 2023, 00:00

  • HPR47 Pricing Lottery or Reasonable Algorithm? Insights From the DiGA Arbitration Board

    Dec 1, 2023, 00:00

  • EE620 Increase in HCM-Related Economic Burden Due to Atrial Fibrillation in Patients with Symptomatic Obstructive Hypertrophic Cardiomyopathy: A Claims Analysis of 9490 Patients

    Dec 1, 2023, 00:00

  • EE724 Inside CKD: Projecting the Population Level Economic Burden of Chronic Kidney Disease According to Urine Albumin-to-Creatinine Ratio (uACR) Categories

    Dec 1, 2023, 00:00

  • EE3 Micro-Costing Analysis for the Treatment of Atrial Fibrillation: An Economic Evaluation

    Dec 1, 2023, 00:00

  • HTA320 Predicting Value and Price of Orphan Drugs: A Comparison Across Europe and the US

    Dec 1, 2023, 00:00

  • RWD90 How to Reduce the Burden of Travel for the Patients? a Proof of Concept (POC) for Oncological Oral Drugs Distribution Points Analysis

    Dec 1, 2023, 00:00

  • SA21 Feasibility Assessment of an Indirect Treatment Comparison (ITC) of Sacituzumab Govitecan (SG) Vs Trastuzumab Deruxtecan (T-DxD) in HR+/HER2– Metastatic Breast Cancer (mBC)

    Dec 1, 2023, 00:00

  • MSR115 Using Machine Learning to Assess Potential Cases of Transthyretin Cardiac Amyloidosis in Brazil: A Retrospective Database Approach

    Dec 1, 2023, 00:00

  • EPH206 Public Health Impact of Nirsevimab Against Lower Respiratory Infections Associated with Respiratory Syncytial Virus Among Chinese Infants

    Dec 1, 2023, 00:00

  • EE543 Cost and Opportunity in Hemophilia: The Economic Impact of Drug Treatment

    Dec 1, 2023, 00:00

  • HTA9 Success Rate of Cancer Drugs Fund Reappraisals

    Dec 1, 2023, 00:00

  • HPR82 The Comparative Analysis of Accelerated Coverage Pathways for Innovation (ACPI) for Digital Technologies: In the Landscape of Germany, France, and the United Kingdom

    Dec 1, 2023, 00:00

  • MSR43 Flexible Parametric and Semi-Parametric Non-Markov Multi-State Models: Estimation, Prediction Simulation

    Dec 1, 2023, 00:00

  • MSR68 How to Choose the Right Insulin in Patients with Type 2 Diabetes: A Joint Modeling Method

    Dec 1, 2023, 00:00

  • HPR107 Bilateral Price Comparison of 50 Particularly Cost-Intensive Drugs – What Is the Impact of Different Reimbursement Rules?

    Dec 1, 2023, 00:00

  • HPR139 Access to Targeted Therapies for Solid Tumors in Turkey

    Dec 1, 2023, 00:00

  • HTA13 Broadening the Scope: Analysis of Oncology Reimbursement Decisions Following the Cancer Drugs List Introduction in Singapore

    Dec 1, 2023, 00:00

  • PCR21 Patient Preferences and Expectations Regarding Leukemia and Lymphoma Treatment: Improving Patient Engagement in Portugal through Quantitative and Qualitative Findings

    Dec 1, 2023, 00:00

  • EE182 Costs and Health Impact of Wastewater Surveillance to Guide Respiratory Syncytial Virus Prophylaxis in Canada, Compared to Clinical Surveillance

    Dec 1, 2023, 00:00

  • HPR162 Pharmaceutical Rebates – An Anglo-French Comparison

    Dec 1, 2023, 00:00

  • EE459 Lifetime Healthcare and Long-Term Care Use of Heart Failure Patients in the Netherlands

    Dec 1, 2023, 00:00

  • EE561 The Comparative Pharmacoeconomic Analysis of Using Different Anti-VEGF Drugs for Diabetic Macular Edema Therapy in Russia

    Dec 1, 2023, 00:00

  • HPR5 Implementing a Value-Based Payment Model for Patients with Osteoarthritis

    Dec 1, 2023, 00:00

  • EE617 A Systematic Review of Economic Evaluations of Balloons and Stents for Patients With Coronary Artery Disease Undergoing Percutaneous Coronary Intervention

    Dec 1, 2023, 00:00

  • CO155 Trial-Level Endpoint Surrogacy Analysis: Feasibility Assessment and Comparison of Different Methodological Approaches

    Dec 1, 2023, 00:00

  • EE150 Usage of Social Return on Investment Modelling in the Analysis of Healthcare Interventions: A Review of Current Utilization

    Dec 1, 2023, 00:00

  • EE270 Predicting Persistent Severe Acute Kidney Injury (AKI) Using the Urinary C-C Motif Chemokine Ligand 14 Biomarker (CCL14). Cost-Utility Analysis in Spain and the UK

    Dec 1, 2023, 00:00

  • EE30 Framework Concepts for Economic Evaluation of New Antibiotics

    Dec 1, 2023, 00:00

  • HTA94 Challenges Facing the Health Technology Assessment (HTA) Submissions of Second Line Treatments for Advanced Oncology

    Dec 1, 2023, 00:00

  • CO25 A Systematic Literature Review (SLR) of the Clinical Efficacy and Safety Evidence Associated with Treatment of Patients with Higher-Risk Myelodysplastic Syndrome (HR-MDS)

    Dec 1, 2023, 00:00

  • CO168 A Propensity Score-Based Comparison of Tepotinib Versus Immunotherapy with/without Chemotherapy, Using Real-World Data in Previously Untreated Met Exon 14 (METEX14) Skipping Non-Small Cell Lung Cancer (NSCLC)

    Dec 1, 2023, 00:00

  • RWD113 Switching to TNFi Versus Non-TNFi Biologics in Ulcerative Colitis Patients: Real-World Outcomes from a German Claims Data Analysis

    Dec 1, 2023, 00:00

  • PCR187 Patient-Reported Outcomes in Phase III Randomized Controlled Trials Evaluating First-Line Treatments in Advance/Metastatic Renal Cell Carcinoma: A Systematic Literature Review

    Dec 1, 2023, 00:00

  • EPH244 Late-Stage Cancer Diagnosis and Systemic Therapy in England Since 2018

    Dec 1, 2023, 00:00

  • MSR53 Flexsurv Methods to Estimate Cure: An Exploration of Methods for Modelling Cure

    Dec 1, 2023, 00:00

  • MT46 Implementation of Cost-Consequences Analysis As an Economic Evaluation Method for Artificial Intelligent (AI) Medical and Digital Technologies. the Case of Hosmartai (HORIZON 2020 FUNDED)

    Dec 1, 2023, 00:00

  • EE380 Budget-Impact Analysis of Encorafenib with Binimetinib for Unresectable or Metastatic Melanoma in BRAFV600-Mutated Patients in an Argentinian Social Security Payer Setting

    Dec 1, 2023, 00:00

  • MSR105 Construction of External-Control Arms (ECA) in Relapsed and Refractory Multiple Myeloma (RRMM)

    Dec 1, 2023, 00:00

  • PCR272 Qualitative Research to Explore Womens Experience of Vasomotor Symptoms and Evaluate the Suitability of Patient-Reported Outcomes

    Dec 1, 2023, 00:00

  • PCR215 Usability Testing of a Non-Consumer Smartphone Device for ePRO Data Collection

    Dec 1, 2023, 00:00

  • MT27 Does Da Vinci Multiport Experience Help a Surgeon Learn the New Da Vinci Single Port System When Performing a Radical Prostatectomy?

    Dec 1, 2023, 00:00

  • HSD108 Evaluating Electronic Therapeutic Protocols (ETPS) for Diabetes and Heart Failure in Gree Results from a Quantitative Survey Amongst Practicing Physicians

    Dec 1, 2023, 00:00

  • P23 Evolving Use of Artificial Intelligence and Machine Learning in Systematic Literature Reviews (SLRs)

    Dec 1, 2023, 00:00

  • MSR129 Web Tool Development to Ease the Process of Performing the Meta-Analysis of Kaplan-Meier Curves Published in Various Studies

    Dec 1, 2023, 00:00

  • EE739 Assessing the Value of Next Generation Sequencing in NSCLC

    Dec 1, 2023, 00:00

  • EE16 Budget Impact Analysis of the Introduction of Dexcom ONE for the Treatment of Patients With T2 Diabetes on an Intensive Insulin Schedule From the Perspective of the Italian Healthcare Payer

    Dec 1, 2023, 00:00

  • HTA198 Comparisons of Economic Evaluation Guidelines Between Japan and Six Countries (England, France, Germany, Sweden, Canada and Australia)

    Dec 1, 2023, 00:00

  • EPH203 The Prevalence of Alopecia Areata in Germany: Results of an Insurance Claims Database Analysis

    Dec 1, 2023, 00:00

  • PCR11 Humanistic and Economic Burden of Multiple System Atrophy: A Systematic Review

    Dec 1, 2023, 00:00

  • HPR175 Estimating the Impact of the Elective Recovery Plan on Reducing Elective Waiting Lists in England

    Dec 1, 2023, 00:00

  • EPH241 Labor-Market Affiliation Among Danish Migraine Patients Discontinuing Triptan Treatment—A Register-Based Study

    Dec 1, 2023, 00:00

  • CO101 Multiple Myeloma (MM) Refractory to Lenalidomide: A Systematic Literature Review (SLR) of Randomised Controlled Trials (RCTs)

    Dec 1, 2023, 00:00

  • Psychometric Comparison of EQ-5D-Y, CHU-9D, and PedsQL 4.0 in Chinese Children and Adolescents With Functional Dyspepsia: A Multicenter Study

    Dec 1, 2023, 00:00

  • EE198 A Targeted Literature Review of Treatment Sequencing Approaches in Economic Analyses in Relapsing Multiple Sclerosis

    Dec 1, 2023, 00:00

  • PCR37 The Impact of Leber’s Heredity Optic Neuropathy (LHON) on Quality of Life (QoL): A Systematic Literature Review (SLR)

    Dec 1, 2023, 00:00

  • RWD94 Adaptation and Validation of a Natural Language Processing Algorithm to Use in Electronic Health Records to Identify Patients with Progressive Fibrosing-Interstitial Lung Disease in Spain

    Dec 1, 2023, 00:00

  • EE296 Should Hospitals Do Contract Research? Costs, Net Monetary Benefit, and Return on Public Sector Investments in Research at Kuopio University Hospital

    Dec 1, 2023, 00:00

  • RWD149 Real-Life Dose Escalation of Patients with Ulcerative Colitis and Crohn’s Disease Undergoing Biologic Treatment in Portugal

    Dec 1, 2023, 00:00

  • EE325 Healthcare Resource Use and Costs Associated with Obesity and Obesity-Related Complications in Saudi Arabia

    Dec 1, 2023, 00:00

  • EE156 Assessing Treatment Costs and Economic Burden of Major Cardiovascular Conditions in Turkiye

    Dec 1, 2023, 00:00

  • EE475 Economic Burden on Diabetes and Cardiovascular Disease: Real World Data and Empirical Analysis in Algeria

    Dec 1, 2023, 00:00

  • PT34 Impact in Health Outcomes of PD-(L)1 Inhibitors to Treat Early Stages Cancers in Switzerland

    Dec 1, 2023, 00:00

  • EE563 Cost-Effectiveness of the PPARγ Modulator N-Acetyl-Ged-0507-34-Levo (NAC-GED 5%) Versus Benzoyl Peroxide-Adapalene for Moderate to Severe Acne

    Dec 1, 2023, 00:00

  • SA59 Clinical Evidence on Acanthamoeba Keratitis Treatments: Systematic Literature Review

    Dec 1, 2023, 00:00

  • P50 Joint Modelling of Intermediate Longitudinal Biomarkers to Predict Overall Survival in Patients with Solid Tumors

    Dec 1, 2023, 00:00

  • EE391 The Economic Burden of Varicella Among Children in Fran A Societal Perspective

    Dec 1, 2023, 00:00
  • «
  • 11 (current)
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • »